Aurinia Pharmaceuticals Inc.
(Toronto Stock Exchange : AUPH)

( )
AUPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.98%81.590.9%$637.74m
CELGCelgene Corporation
-0.88%135.961.1%$563.57m
AMGNAmgen Inc.
-1.16%184.121.1%$451.54m
BIIBBiogen Inc.
-0.63%342.421.2%$397.97m
REGNRegeneron Pharmaceuticals, Inc.
0.36%440.942.7%$313.46m
ALNYAlnylam Pharmaceuticals, Inc
-1.63%115.6310.7%$252.14m
VRTXVertex Pharmaceuticals Incorporated
-0.10%154.601.9%$218.27m
INCYIncyte Corporation
-0.76%114.272.5%$205.56m
ALXNAlexion Pharmaceuticals, Inc.
0.16%140.461.9%$180.37m
EXELExelixis, Inc.
-0.25%27.466.5%$136.95m
ILMNIllumina, Inc.
-0.21%205.183.5%$132.63m
BLUEBluebird Bio, Inc.
0.25%139.4517.3%$114.79m
BMRNBioMarin Pharmaceutical Inc.
-0.55%88.134.4%$113.12m
SRPTSarepta Therapeutics, Inc.
-1.36%50.7216.9%$105.98m
CLVSClovis Oncology, Inc.
-2.48%76.7716.5%$102.15m

Company Profile

Aurinia Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on discovering and developing immunomodulating therapeutics. The company's pipeline includes voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals was founded by Robert Foster, Richard Glickman and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.